Bionomics

Prestwick Chemical is a French Contract Research Organization (CRO) established in 1999 by Professor C.G. Wermuth, who is renowned in the fields of pharmacology and medicinal chemistry. The company specializes in early drug discovery, offering smart chemical screening libraries and tailored medicinal chemistry services aimed at accelerating the development of innovative small molecule drugs. Prestwick Chemical serves a diverse clientele, including pharmaceutical and biotechnology companies, research institutes, and academic groups, while also engaging in projects related to cosmetics, veterinary medicine, and agro-pharmaceuticals. Recognized internationally for its contributions to enhancing the drug discovery process, the company focuses on maximizing chemical diversity in its libraries to support both low and high-throughput screening, thereby optimizing the chances of success in hit finding through fragment-based drug discovery.

Eclipse Therapeutics, Inc. is a private biotechnology company focused on the discovery and development of innovative therapeutics aimed at targeting cancer stem cells (CSCs). The company employs a unique biotechnology platform to create novel therapeutic products that address various forms of cancer treatment. Through its specialized approach, Eclipse Therapeutics seeks to advance the understanding and management of cancer by developing effective solutions that specifically target the underlying mechanisms of cancer stem cells.

Iliad Chemicals Pty Limited develops a library of novel molecules that act as potent tubulin polymerisation inhibitors for treating cancer. The company utilizes MultiCore Chemistry technology platform to provide synthesis of molecules and develop chemical libraries.